From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference84 articles.
1. Protein kinases and phosphatases in the control of cell fate;Bononi;Enzyme Res,2011
2. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining;Rowley;Nature,1973
3. Multiple pathways regulated by the tumor suppressor PP2A in transformation;Westermarck;Trends Mol Med,2008
4. Chronic myeloid leukemia: mechanisms of blastic transformation;Perrotti;J Clin Invest,2010
5. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference;Cancers;2024-05-23
2. Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy;Cancer Discovery;2024-03-26
3. SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML;Oncogene;2023-10-27
4. Novel SETBP1 mutation in a chinese family with intellectual disability;BMC Medical Genomics;2023-10-05
5. A pigmentary manifestation associated with PPP2R5D-related neurodevelopmental disorder: a case report and review of literature;Bulletin of the National Research Centre;2023-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3